IS6876A - Aðferð til að framleiða mesýlöt af píperasín afleiðum - Google Patents

Aðferð til að framleiða mesýlöt af píperasín afleiðum

Info

Publication number: IS6876A
Authority: IS; Iceland
Prior art keywords: mesylates; producing; piperazine derivatives; piperazine; derivatives
Prior art date: 2001-02-16

Application number

IS6876A

Other languages

English (en)

Other versions

IS2417B (is

Inventor

P.M. Van Aar Marcel

J. Schouten Stefanus

Zorgdrager Jan

C. Heslinga Michiel

Original Assignee

Solvay Pharmaceuticals B.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-16

Filing date

2003-07-17

Publication date

2003-07-17

2003-07-17 Application filed by Solvay Pharmaceuticals B.V. filed Critical Solvay Pharmaceuticals B.V.

2003-07-17 Publication of IS6876A publication Critical patent/IS6876A/is

2008-10-15 Publication of IS2417B publication Critical patent/IS2417B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

IS6876A 2001-02-16 2003-07-17 Aðferð til að framleiða mesýlöt af píperasín afleiðum IS2417B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01200534		2001-02-16
PCT/EP2002/001666 WO2002066449A2 (en)	2001-02-16	2002-02-14	Process for the preparation of mesylates of piperazine derivatives

Publications (2)

Publication Number	Publication Date
IS6876A true IS6876A (is)	2003-07-17
IS2417B IS2417B (is)	2008-10-15

Family

ID=8179894

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6876A IS2417B (is)	2001-02-16	2003-07-17	Aðferð til að framleiða mesýlöt af píperasín afleiðum

Country Status (35)

Country	Link
US (1)	US7030241B2 (is)
EP (1)	EP1362040B1 (is)
JP (1)	JP4328528B2 (is)
KR (2)	KR101000733B1 (is)
CN (1)	CN1176079C (is)
AR (1)	AR034206A1 (is)
AT (1)	ATE284875T1 (is)
AU (1)	AU2002250962B2 (is)
BG (1)	BG66101B1 (is)
BR (1)	BR0205683A (is)
CA (1)	CA2422703C (is)
CZ (1)	CZ301780B6 (is)
DE (1)	DE60202261T2 (is)
DK (1)	DK1362040T3 (is)
DZ (1)	DZ3489A1 (is)
ES (1)	ES2230481T3 (is)
HK (1)	HK1059934A1 (is)
HR (1)	HRP20030610B1 (is)
HU (1)	HUP0400772A3 (is)
IL (1)	IL153509A (is)
IS (1)	IS2417B (is)
ME (1)	MEP37508A (is)
MX (1)	MXPA03002359A (is)
MY (1)	MY130687A (is)
NO (1)	NO324460B1 (is)
NZ (1)	NZ524632A (is)
PL (1)	PL208363B1 (is)
PT (1)	PT1362040E (is)
RS (1)	RS51126B (is)
RU (1)	RU2272036C2 (is)
SI (1)	SI1362040T1 (is)
SK (1)	SK286143B6 (is)
UA (1)	UA75390C2 (is)
WO (1)	WO2002066449A2 (is)
ZA (1)	ZA200301590B (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7435738B2 (en)	2003-08-18	2008-10-14	Solvay Pharmaceuticals, Inc.	Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
AR045362A1 (es) *	2003-08-18	2005-10-26	Solvay Pharm Bv	Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
US7405216B2 (en) *	2004-08-18	2008-07-29	Solvay Pharmaceuticals, B.V.	Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7964604B2 (en) *	2005-02-18	2011-06-21	Solvay Pharmaceuticals B.V.	Bifeprunox mesylate maintenance dose compositions and methods for using the same
US7423040B2 (en) *	2005-02-18	2008-09-09	Irene Eijgendaal	Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US20070275977A1 (en) *	2006-05-02	2007-11-29	Van Aar Marcel P	N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US7786126B2 (en) *	2006-06-16	2010-08-31	Solvay Pharmaceuticals B.V.	Combination preparations comprising SLV308 and a dopamine agonist
US8106056B2 (en)	2006-06-16	2012-01-31	Solvay Pharmaceuticals B.V.	Combination preparations comprising bifeprunox and a dopamine agonist
US20080132520A1 (en) *	2006-08-31	2008-06-05	Winsemius Antje A	Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds
BRPI0715445A2 (pt)	2006-08-31	2014-05-13	Solvay Pharm Bv	Uso de um composto de bifeprunox, e, kit de titulação
US20090068290A1 (en) *	2006-08-31	2009-03-12	Michel Bourin	Bifeprunox doses for treating schizophrenia
JP2011511011A (ja)	2008-02-05	2011-04-07	ハーバーバイオサイエンシーズ，インコーポレイテッド	医薬的固体状態形態
WO2011023796A1 (en)	2009-08-31	2011-03-03	Abbott Healthcare Products B.V.	Bifeprunox for treating addiction
UY32935A (es)	2009-10-12	2011-05-31	Abbott Healthcare Products Bv	Polimorfos de pardoprunox

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3586794T2 (de)	1984-12-21	1993-05-27	Duphar Int Res	Arzneimittel mit psychotroper wirkung.
EP0190472B1 (en) *	1984-12-21	1989-07-12	Duphar International Research B.V	New pharmaceutical compositions having anti-psychotic properties
JPH0344383A (ja) *	1989-07-12	1991-02-26	Ihara Chem Ind Co Ltd	５―トリフルオロメチル―２―ハロメチルベンゾチアゾール類の製造法
JP3044383B2 (ja) *	1990-05-22	2000-05-22	コニカ株式会社	含窒素６員環化合物の製造方法
TR199801942T2 (xx) *	1996-03-29	2000-08-21	Duphar International Research B.V.	Piperazin ve piperidin bile�ikleri.
SE9702799D0 (sv) *	1997-07-25	1997-07-25	Astra Ab	New compounds
UA71590C2 (en) *	1998-11-13	2004-12-15	Duphar Int Res	Piperazine and piperidine derivatives
US7435738B2 (en) *	2003-08-18	2008-10-14	Solvay Pharmaceuticals, Inc.	Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

2002
- 2002-02-12 AR ARP020100460A patent/AR034206A1/es active IP Right Grant
- 2002-02-14 SI SI200230061T patent/SI1362040T1/xx unknown
- 2002-02-14 ME MEP-375/08A patent/MEP37508A/xx unknown
- 2002-02-14 SK SK309-2003A patent/SK286143B6/sk not_active IP Right Cessation
- 2002-02-14 IL IL153509A patent/IL153509A/en not_active IP Right Cessation
- 2002-02-14 DK DK02719858T patent/DK1362040T3/da active
- 2002-02-14 AT AT02719858T patent/ATE284875T1/de active
- 2002-02-14 UA UA2003098528A patent/UA75390C2/uk unknown
- 2002-02-14 CN CNB028016858A patent/CN1176079C/zh not_active Expired - Fee Related
- 2002-02-14 PL PL369330A patent/PL208363B1/pl unknown
- 2002-02-14 JP JP2002565965A patent/JP4328528B2/ja not_active Expired - Fee Related
- 2002-02-14 NZ NZ524632A patent/NZ524632A/en not_active IP Right Cessation
- 2002-02-14 DE DE60202261T patent/DE60202261T2/de not_active Expired - Lifetime
- 2002-02-14 MX MXPA03002359A patent/MXPA03002359A/es active IP Right Grant
- 2002-02-14 BR BR0205683-6A patent/BR0205683A/pt not_active Application Discontinuation
- 2002-02-14 EP EP02719858A patent/EP1362040B1/en not_active Expired - Lifetime
- 2002-02-14 CA CA2422703A patent/CA2422703C/en not_active Expired - Fee Related
- 2002-02-14 RS YUP-644/03A patent/RS51126B/sr unknown
- 2002-02-14 AU AU2002250962A patent/AU2002250962B2/en not_active Ceased
- 2002-02-14 KR KR1020087015071A patent/KR101000733B1/ko not_active IP Right Cessation
- 2002-02-14 MY MYPI20020505A patent/MY130687A/en unknown
- 2002-02-14 WO PCT/EP2002/001666 patent/WO2002066449A2/en active IP Right Grant
- 2002-02-14 ES ES02719858T patent/ES2230481T3/es not_active Expired - Lifetime
- 2002-02-14 HU HU0400772A patent/HUP0400772A3/hu unknown
- 2002-02-14 KR KR1020037000026A patent/KR100859106B1/ko not_active IP Right Cessation
- 2002-02-14 RU RU2003105902/04A patent/RU2272036C2/ru not_active IP Right Cessation
- 2002-02-14 DZ DZ023489A patent/DZ3489A1/fr active
- 2002-02-14 US US10/468,098 patent/US7030241B2/en not_active Expired - Fee Related
- 2002-02-14 PT PT02719858T patent/PT1362040E/pt unknown
- 2002-02-14 CZ CZ20030697A patent/CZ301780B6/cs not_active IP Right Cessation
2003
- 2003-02-26 ZA ZA200301590A patent/ZA200301590B/en unknown
- 2003-04-15 NO NO20031754A patent/NO324460B1/no not_active IP Right Cessation
- 2003-07-17 IS IS6876A patent/IS2417B/is unknown
- 2003-07-28 HR HR20030610A patent/HRP20030610B1/xx not_active IP Right Cessation
- 2003-08-13 BG BG108090A patent/BG66101B1/bg unknown
2004
- 2004-04-22 HK HK04102835A patent/HK1059934A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IS2417B (is)	2008-10-15
DE60202261D1 (de)	2005-01-20
PT1362040E (pt)	2005-05-31
BR0205683A (pt)	2004-07-06
AU2002250962B2 (en)	2006-08-24
NO20031754L (no)	2003-04-15
HRP20030610A2 (en)	2005-06-30
JP2004518741A (ja)	2004-06-24
HUP0400772A2 (hu)	2004-08-30
ZA200301590B (en)	2004-02-05
EP1362040B1 (en)	2004-12-15
US20040077631A1 (en)	2004-04-22
AR034206A1 (es)	2004-02-04
KR101000733B1 (ko)	2010-12-14
CN1463268A (zh)	2003-12-24
UA75390C2 (en)	2006-04-17
EP1362040A2 (en)	2003-11-19
IL153509A (en)	2007-12-03
NO324460B1 (no)	2007-10-22
IL153509A0 (en)	2003-07-06
CA2422703A1 (en)	2002-08-29
JP4328528B2 (ja)	2009-09-09
BG108090A (bg)	2004-12-30
HUP0400772A3 (en)	2008-02-28
SK3092003A3 (en)	2003-09-11
CZ301780B6 (cs)	2010-06-23
ES2230481T3 (es)	2005-05-01
DE60202261T2 (de)	2005-05-19
SI1362040T1 (en)	2005-06-30
HRP20030610B1 (en)	2006-02-28
PL369330A1 (en)	2005-04-18
WO2002066449A3 (en)	2002-10-24
DK1362040T3 (da)	2005-01-24
MY130687A (en)	2007-07-31
PL208363B1 (pl)	2011-04-29
KR20030077523A (ko)	2003-10-01
CZ2003697A3 (cs)	2003-06-18
RS51126B (sr)	2010-10-31
NO20031754D0 (no)	2003-04-15
ATE284875T1 (de)	2005-01-15
MEP37508A (en)	2011-02-10
CN1176079C (zh)	2004-11-17
NZ524632A (en)	2004-03-26
SK286143B6 (sk)	2008-04-07
US7030241B2 (en)	2006-04-18
HK1059934A1 (en)	2004-07-23
KR20080064206A (ko)	2008-07-08
KR100859106B1 (ko)	2008-09-18
CA2422703C (en)	2010-04-13
RU2272036C2 (ru)	2006-03-20
DZ3489A1 (fr)	2002-08-29
BG66101B1 (bg)	2011-04-29
MXPA03002359A (es)	2003-06-30
WO2002066449A2 (en)	2002-08-29
YU64403A (sh)	2006-05-25

Publication	Publication Date	Title
DK1312406T3 (da)	2007-11-05	Fremgangsmåde til rensning af syntesegas
DK1412459T3 (da)	2007-11-26	Fremgangsmåde til fremstilling af mellemdestillater
DK1303478T3 (da)	2004-08-30	Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1223474T3 (da)	2008-03-31	Fremgangsmåde til fremstilling af estervoks
DK1182261T3 (da)	2011-05-16	Fremgangsmåde til frembringelse af basisk aminosyre
DK1277722T3 (da)	2005-04-25	Fremgangsmåde til fremstilling af methanol
DK1293507T3 (da)	2007-12-27	Fremgangsmåde til fremstilling af krystaller
DK1180544T3 (da)	2006-10-23	Fremgangsmåde til fremstilling af syntesegas
DK2058243T4 (da)	2019-11-04	Fremgangsmåde til fremstilling af drikke
DK1370150T3 (da)	2008-03-25	t-trinsproces til fremstilling af tyggegummi
DK2135957T3 (da)	2019-05-13	Fremgangsmåde til fremstilling af glucaner
NO20033887D0 (no)	2003-09-02	Fremgangsmåte for fremstilling av stöpestykker
IS6876A (is)	2003-07-17	Aðferð til að framleiða mesýlöt af píperasín afleiðum
DK1536685T3 (da)	2006-08-14	Fremgangsmåde til fremstilling af pasta-ekstruderede sulfonamidsammensætninger
IS2979B (is)	2017-09-15	Aðferð til að framleiða N-útskipt 2-sýanópýrrólídín
IS7153A (is)	2004-02-13	Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
DK1401816T3 (da)	2008-06-09	Fremgangsmåde til fremstilling af piperidinderivatet fexofenadin
DK1395587T3 (da)	2009-10-12	Fremgangsmåde til fremstilling af imipenem
DK1511724T3 (da)	2014-06-16	Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1503995T3 (da)	2008-04-21	Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer
DK1262451T3 (da)	2005-08-08	Fremgangsmåde til at fremstille svovldioxid
DK1373232T3 (da)	2006-03-27	Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DK1385806T3 (da)	2005-09-12	Ettrinsfremgangsmåde til fremstilling af trimethoxytoluen
DK1309583T3 (da)	2006-10-16	Fremgangsmåde til fremstilling af discodermolid og analoge deraf
DK1274677T3 (da)	2007-05-21	Fremgangsmåde til fremstilling af oximethere